BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29797496)

  • 1. Polypharmacological Drug-target Inference for Chemogenomics.
    Schneider P; Schneider G
    Mol Inform; 2018 Sep; 37(9-10):e1800050. PubMed ID: 29797496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Docking: Shifting Paradigms in Drug Discovery.
    Pinzi L; Rastelli G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database.
    Wang L; Ma C; Wipf P; Liu H; Su W; Xie XQ
    AAPS J; 2013 Apr; 15(2):395-406. PubMed ID: 23292636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
    Dutta D; Das R; Mandal C; Mandal C
    J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of polypharmacological profiles of drugs by the integration of chemical, side effect, and therapeutic space.
    Cheng F; Li W; Wu Z; Wang X; Zhang C; Li J; Liu G; Tang Y
    J Chem Inf Model; 2013 Apr; 53(4):753-62. PubMed ID: 23527559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on Drug Repurposing: Re-written saga of the drug's fate.
    Gns HS; Gr S; Murahari M; Krishnamurthy M
    Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic study of chemogenomics of carbohydrates.
    Gu J; Luo F; Chen L; Yuan G; Xu X
    Mol Biosyst; 2014 Mar; 10(3):391-7. PubMed ID: 24469441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Computational Approach to Predict Off-Target Interactions for Small Molecules.
    Rao MS; Gupta R; Liguori MJ; Hu M; Huang X; Mantena SR; Mittelstadt SW; Blomme EAG; Van Vleet TR
    Front Big Data; 2019; 2():25. PubMed ID: 33693348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCDB: a glaucomatous chemogenomics database for in silico drug discovery.
    Wei Y; Li J; Li B; Ma C; Xu X; Wang X; Liu A; Du T; Wang Z; Hong Z; Lin J
    Database (Oxford); 2018 Jan; 2018():. PubMed ID: 30371760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chemogenomics view on protein-ligand spaces.
    Strömbergsson H; Kleywegt GJ
    BMC Bioinformatics; 2009 Jun; 10 Suppl 6(Suppl 6):S13. PubMed ID: 19534738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery.
    Lauria A; Bonsignore R; Bartolotta R; Perricone U; Martorana A; Gentile C
    Curr Pharm Des; 2016; 22(21):3073-81. PubMed ID: 26907944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Target Interactions: Prediction Methods and Applications.
    Anusuya S; Kesherwani M; Priya KV; Vimala A; Shanmugam G; Velmurugan D; Gromiha MM
    Curr Protein Pept Sci; 2018; 19(6):537-561. PubMed ID: 27829350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemistry-driven Hit-to-lead Optimization Guided by Structure-based Approaches.
    Hoffer L; Muller C; Roche P; Morelli X
    Mol Inform; 2018 Sep; 37(9-10):e1800059. PubMed ID: 30051601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
    Bieler M; Heilker R; Köppen H; Schneider G
    J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive in silico off-target profiling in drug discovery.
    Schmidt F; Matter H; Hessler G; Czich A
    Future Med Chem; 2014 Mar; 6(3):295-317. PubMed ID: 24575966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDR Targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration.
    Urán Landaburu L; Berenstein AJ; Videla S; Maru P; Shanmugam D; Chernomoretz A; Agüero F
    Nucleic Acids Res; 2020 Jan; 48(D1):D992-D1005. PubMed ID: 31680154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DT-Web: a web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference.
    Alaimo S; Bonnici V; Cancemi D; Ferro A; Giugno R; Pulvirenti A
    BMC Syst Biol; 2015; 9 Suppl 3(Suppl 3):S4. PubMed ID: 26050742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance in the research and discovery of novel drugs based on chemogenomics].
    He BK; Ma ZC; Wang YG; Gao Y
    Yao Xue Xue Bao; 2008 Nov; 43(11):1077-81. PubMed ID: 19239023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.